Rupert Murdoch takes on ranching

Jan 04, 2022

Media mogul Rupert Murdoch buys cattle ranch in Montana in the largest such deal in the state’s history.

From media mogul to farmer, billionaire continues his climb upwards.
In the largest ranch deal in Montana history. Rupert Murdoch, 90, and his wife, Jerry, purchased a 340,000 acre ranch in southwest Montana, near Yellowstone National Park.

The deal—which happened this past December—is for the property known as Beaverhead Ranch, and was purchased from Matador Cattle Co., a subsidiary of Koch Industries for about US$200-million (~CDN$255-million).

Koch Industries was founded by Fred Koch, who founded the crude-oil-gathering business that grew into Koch Industries. He purchased the ranch about seven decades previous.

Murdoch—owner of HarperCollins, the Wall Street Journal, and hundreds of other well-known media enterprises—said he had been looking for a ranch property for over a year.

He added that he was “privileged to assume ownership of this beautiful land” and that along with anticipating spending time at the ranch, will enhance the commercial cattle business and its conservation assets.

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.